In Vitro and In Vivo Potency of Moxifloxacin and Moxifloxacin Ophthalmic Solution 0.5%, A New Topical Fluoroquinolone

Fluoroquinolones are a class of synthetic antibacterial agents that were approved for ocular therapy in 1991 and have become popular therapy for the treatment and prevention of various ocular infections. These agents are synthetic, broad-spectrum, rapidly bactericidal, and have good penetration into...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Survey of ophthalmology 2005-11, Vol.50 (6), p.S16-S31
Hauptverfasser:	Stroman, David W., Dajcs, Joseph J., Cupp, Gale A., Schlech, Barry A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Topical Animals antibiotic activity antibiotic potency antibiotic resistance Aza Compounds - pharmacology Aza Compounds - therapeutic use Bacteria - drug effects Corneal Ulcer - drug therapy Corneal Ulcer - microbiology Disease Models, Animal Drug Resistance, Microbial Eye Infections, Bacterial - drug therapy Eye Infections, Bacterial - microbiology Fluoroquinolones Humans in vitro In Vitro Techniques in vivo Microbial Sensitivity Tests MICs moxifloxacin Ophthalmic Solutions - pharmacology Ophthalmic Solutions - therapeutic use Quinolines - pharmacology Quinolines - therapeutic use VIGAMOX
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!